Provider review
Ro Body tirzepatide review
What Ro Body charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
Ro Body is not scored on our v4.1 rubric: ro.co returned HTTP 403 to our reads on November 20 and 21, 2026.
What is distinctive about this programme
The annual plan changes the structure, not just the price
Ro's annual prepayment is reported to cut $50 a month from oral medication and $150 a month from injectable medication, and to halve the membership from $149 to $74. That is a larger structural change than most competitors' prepaid discounts, which typically move only the medication line.
On the monthly plan, Zepbound at $399 medication plus $149 membership is $548 all-in — against $449 direct from LillyDirect with no membership. The annual plan closes most of that gap.
Dose escalation applies
Medication prices run $199 to $399 by dose for injectables and $199 to $299 for orals, so the all-in figure moves with titration. The first month is discounted — $299 medication for Zepbound, $149 for oral — and those are introductory rates excluded from our rankings.
What to weigh
Ro is a large, established platform with substantial clinical infrastructure. The pricing question is whether the service layer justifies $1,788 a year on the monthly plan, or $888 on the annual, when both manufacturers sell direct. For patients who want the platform, the annual plan is materially the better structure; for patients who want the medication at the lowest price, LillyDirect and NovoCare are cheaper.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Semaglutide brand injectable, FDA-approved | $348 | Provider-reported |
Where it holds up
- Annual plan reduces both medication cost and membership, halving the latter to $74
- Large established platform with substantial clinical infrastructure
- Wide brand range including both manufacturers' products
Where it does not
- $149 monthly membership on the standard plan, $1,788 a year
- Zepbound at $548 all-in monthly against $449 direct from LillyDirect
- Medication prices escalate by dose
- First-month rates are introductory
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $348/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Ro | month_to_month | brand injectable, FDA-approved | not recorded | $348 | not verified | $348 | Recurring | Provider-reported | 2026-07-06 |
How this sits against the market
The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | not verified |
| Shipping | no | not verified |
| Higher-dose surcharge | no | not verified |
| Initial consultation | no | not verified |
| Required laboratory work | no | not verified |
| Cancellation or restocking terms | no | not verified |
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Pharmacy and fulfilment
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where Ro Body sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | not verified | Not answered Verification pending |
| Clinical oversight and care continuity | 20 pts | not verified | Not answered Verification pending |
| State access and operational reliability | 10 pts | not verified | Not answered Verification pending |
| Cancellation, billing and support transparency | 10 pts | not verified | Not answered Verification pending |
Questions readers actually ask
Is Ro Body the cheapest option?
Not scored: ro.co returned HTTP 403 to our reads on November 20 and 21, 2026.
Is compounded tirzepatide the same as Zepbound?
No. Compounded tirzepatide is not FDA-approved, is not generic and is not the same product as Zepbound or Mounjaro; it is made with the drug in those products. Brand Zepbound bought through any platform is the FDA-approved product.
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Mochi Health Tirzepatide ReviewProviders
- The 100-point rubricCore & Trust
- Cost calculatorTools
- The underlying price recordsData
- Mounjaro vs ZepboundPillar / Money
- Zepbound vs MounjaroComparisons
- Tirzepatide Cost in 2026Pillar / Money
Related coverage
- PlushCare Tirzepatide Review
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- Sildenafil vs Tadalafil: Duration, Dosing and Which Suits Which Pattern
- Tirzepatide Telehealth by State
- Tirzepatide Telehealth in Alabama
- Tirzepatide Telehealth in Alaska
- Tirzepatide Telehealth in Arizona
- Tirzepatide Telehealth in Arkansas
GLP-1 Tirzepatide Review. “Ro Body Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/ro-body/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.